<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03279029</url>
  </required_header>
  <id_info>
    <org_study_id>2017-08</org_study_id>
    <secondary_id>2017-A00680-53</secondary_id>
    <nct_id>NCT03279029</nct_id>
  </id_info>
  <brief_title>Aortic Valve Regurgitation Acquired After Left Ventricular Assist Device Implantation: an Outstanding in Vivo Model of Valvular Heart Diseases</brief_title>
  <official_title>Aortic Valve Regurgitation Acquired After Left Ventricular Assist Device Implantation: an Outstanding in Vivo Model of Valvular Heart Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate histological structure and molecular changes involved on the onset of AVD
      after left ventricular assist device (LVAD) implantation and to compare them with those of
      patients operated on for severe aortic regurgitation.

      Methods: Bridge-to-transplant patients with AVD post-LVAD implantation are included. Patients
      operated on for severe aortic regurgitation are included as control. Clinical and TTE data
      are compiled. Samples of aortic valve are collected at the time of the intervention.
      RNA-sequencing analysis is performed in LVAD patients and variations of gene expression are
      validated by real time qPCR in both. Blood sampling are performed pre-operatively and at
      one-month follow up to assess the plasma level of previously identified gene modulators.
      In-vitro studies exposing VICs and VECs to several mechanical stimuli are performed for
      validation.

      Conclusion(s) Taking together, the in-vivo and in-vitro models would provide important
      information for the understanding of valve remodeling and disease. ECM gene modulators could
      represent pertinent molecular targets to stop the progression of AVD
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2017</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood sample</measure>
    <time_frame>24 months</time_frame>
    <description>RNA-sequencing analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Aortic Valve Regurgitation Acquired</condition>
  <arm_group>
    <arm_group_label>patients with aortic valve disease (AVD).</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with left ventricular assist device (LVAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>blood samples</description>
    <arm_group_label>patients with aortic valve disease (AVD).</arm_group_label>
    <arm_group_label>patients with left ventricular assist device (LVAD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>biopsy</intervention_name>
    <description>biopsy of aortic valve</description>
    <arm_group_label>patients with aortic valve disease (AVD).</arm_group_label>
    <arm_group_label>patients with left ventricular assist device (LVAD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with long-term left-ventricular assistance awaiting transplant

          -  Patients with severe aortic surgical spring deficiency

          -  Major Patient

        Exclusion Criteria:

          -  Minor Patient

          -  Pregnant or nursing women

          -  Major under guardianship

          -  People in emergencies

          -  Persons not covered by the social security scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>alexis THERON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>alexis THERON</last_name>
    <email>alexis.theron@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>JEAN OLIVIER ARNAUD</last_name>
    <phone>0491382747</phone>
    <email>drci@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JEAN OLIVIER ARNAUD</last_name>
    </contact>
    <investigator>
      <last_name>ALEXIS THERON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2017</study_first_submitted>
  <study_first_submitted_qc>September 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2017</study_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

